XOMA
NASDAQ · Biotechnology
Xoma Royalty Corporation
$40.17
-4.05 (-9.16%)
Open$43.97
Previous Close$44.22
Day High$43.97
Day Low$39.77
52W High$45.22
52W Low$22.29
Volume—
Avg Volume882.3K
Market Cap710.16M
P/E Ratio21.00
EPS$2.00
SectorBiotechnology
Analyst Ratings
Buy
9 analysts
Price Target
-0.4% upside
Current
$40.17
$40.17
Target
$40.02
$40.02
$30.13
$40.02 avg
$66.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 51.27M | 33.35M | 45.56M |
| Net Income | 31.18M | -14,563,878 | -2,452,418 |
| Profit Margin | 60.8% | -46.1% | -5.4% |
| EBITDA | 34.97M | -22,420,452 | -2,902,540 |
| Free Cash Flow | — | — | -1,967,070 |
| Rev Growth | +105.3% | -9.3% | +14.7% |
| Debt/Equity | 1.05 | 1.44 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |